TOP TIERMARKET NEWSWIRE

News & sentiment

CRINETICS PHARMACEUT (CRNX) — News & AI sentiment

CRINETICS PHARMACEUT (CRNX) news roundup. 4 stories in the past week, 46 over 30 days. Average 30-day sentiment is 64.1/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $366K — net selling of $366K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

4

avg sentiment 48.3/100

30d stories

46

avg sentiment 64.1/100

Insider net (90d)

$366K

0 buys · 2 sells

Congress (90d)

0

0 buys · 0 sells

Latest stories on CRNX

UBS downgrades Crinetics stock rating on Vertex acquisition

Investing.com Analyst Ratings34 · bearishm&a

2d ago

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG

PR Newswire50 · neutralm&a

7d ago

Biotech stocks lead healthcare's overbought list as earnings picks up

Seeking Alpha56 · neutralearnings

7d ago

Vertex was sole bidder in high-premium Crinetics acquisition

Yahoo Finance53 · neutralm&a

Jul 22

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESI, CRNX, SOLS, and PATK

PR Newswire50 · neutralm&a

Jul 16

Vertex to Acquire Crinetics Pharmaceuticals (CRNX) in $85 Per Share Cash Deal

Yahoo Top73 · bullishm&a

Jul 15

Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals

The Motley Fool63 · neutralm&a

Jul 14

Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse

Yahoo Top63 · neutralm&a

Jul 11

Key deals this week: MGM, PERF, VRTX, and more

Seeking Alpha50 · neutralm&a

Jul 11

Crinetics Pharmaceuticals, Inc. (CRNX) files 8-K

SEC 8-K50 · neutralgeneral

Jul 10

Why Crinetics Stock Soared 99% This Week

Yahoo Finance94 · bullishm&a

Jul 9

Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?

Yahoo Top57 · neutralanalyst

Jul 8

Vertex’s Crinetics Deal Balances Growth with Integration Risk

MarketBeat63 · neutralm&a

Jul 8

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

The Motley Fool63 · neutralm&a

Jul 8

VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?

Stocktwits News65 · bullishanalyst

Jul 8

Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know.

The Motley Fool65 · bullishm&a

Jul 8

Stocks making the biggest moves midday: SpaceX, GE Vernova, Crinetics Pharmaceuticals, Rivian & more

CNBC50 · neutralgeneral

Jul 7

SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers

Bloomberg54 · neutralgeneral

Jul 7

Vertex’s $10 Billion Acquisition of Crinetics Brings Blockbuster Endocrine Drugs and Pipeline to Forefront July 7, 2026

MarketChameleon88 · bullishm&a

Jul 7

Cantor Sees 'Clear Strategic Rationale' Behind Vertex's Buy of Crinetics — Market Talk

Morningstar67 · bullishm&a

Jul 7

Vertex To Acquire Crinetics For ~$10bn - What Investors Should Know

Seeking Alpha73 · bullishm&a

Jul 7

Vertex Pharmaceuticals buying Crinetics for $10 billion - qz.com

Quartz68 · bullishm&a

Jul 7

Vertex Sees Over $5 Billion Peak Sales Potential From Crinetics Assets

Yahoo Top73 · bullishm&a

Jul 7

This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal

Barron's88 · bullishm&a

Jul 7

At a glance: stocks gapping up premarket

Seeking Alpha58 · neutralgeneral

Jul 7

Open CRNX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →